The well-funded biotech lost most of its value after its drug flunked a late-stage trial. One analyst described the results ...

In zebrafish, ketamine causes changes a brain circuit involved in "giving up." That may help explain how the drug helps ...

Neumora Therapeutics Inc.’s shares plummeted after the company’s experimental drug failed to show a benefit in a final-stage ...

Neuroscience company Neumora Therapeutics (NMRA) announced today that its experimental treatment for depression, Navacaprant, ...

Studies show that antidepressants don’t always work. One psychologist explains how to take control of negative thoughts ...

Patients who received the drug, called navacaprant, showed no more improvement in depressive symptoms than people who ...

The study, first of the three late-stage trials, was testing the drug, navacaprant, in patients with major depressive ...

Neumora Therapeutics, Inc. (NASDAQ:NMRA) stock traded lower after the company released data from the Phase 3 KOASTAL-1 Study ...

Studies show psilocybin from mushrooms could revolutionize depression treatment offering hope to millions who don't respond ...

Neumora Therapeutics Inc. (NASDAQ: NMRA) nosedived by more than 80 percent during pre-market trading following disappointing ...